^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
MammaTyper® Kit

Type:
CE Marked
Related tests:
Evidence Level:
Sensitive: C3 – Early Trials

[AR overexpression-Breast Cancer-paclitaxel]

Title:
Androgen receptor expression and response to chemotherapy in breast cancer patients treated in the neoadjuvant TECHNO and PREPARE trial
Excerpt:
In the PREPARE trial, a dose-dense treatment arm was compared with a standard treatment arm. Regarding overall survival, patients with high AR1 mRNA levels receiving the standard treatment had better survival compared to patients with low AR1 mRNA levels (HR 0.41 (95% CI 0.22–0.74)...
Secondary therapy:
EC
DOI:
10.1038/s41416-019-0630-3
Trial ID: